. . . . . . . . . "a(SCHEM:Infliximab) -| bp(MESHPP:\"Insulin Resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "More recent observations with the TNFa antibody infliximab, currently prescribed to treat rheumatoid arthritis, point to a possible benefit regarding insulin sensitivity" . . "Selventa" . . . . "2014-07-03T14:30:38.659+02:00"^^ . . .